Chunliang Li, PhD, St. Jude Department of Tumor Cell Biology, along with his team and collaborators, identified RBM5 as key player in HOXA9-linked AML development, also revealing an unexpected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback